Fingerprint
Dive into the research topics of 'Phase i study of CHK1 inhibitor LY2603618 in combination with gemcitabine in patients with solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase i study of CHK1 inhibitor LY2603618 in combination with gemcitabine in patients with solid tumors
Emiliano Calvo, Fadi Braiteh, Daniel Von Hoff, Robert McWilliams, Carlos Becerra, Matthew D. Galsky, Gayle Jameson, Ji Lin, Scott McKane, Enaksha R. Wickremsinhe, Scott M. Hynes, Aimee Bence Lin, Karla Hurt, Donald Richards
Research output: Contribution to journal › Article › peer-review
23
Scopus
citations